Original Contributions |
From the Department of Cardiovascular Medicine, University of New South Wales, Prince Henry/Prince of Wales Hospitals, Sydney, Australia (X.L.W., A.S.S., D.E.L.W.), and the Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University, 5-6-1 Mitahora-higashi, Gifu, Japan (T.A.).
Correspondence to Dr X.L. Wang, Department of Cardiovascular Medicine, Edmund Blacket Building, Ground Floor, Prince of Wales Hospital, Avoca St, Randwick, NSW 2031, Australia. E-mail x.l.wang{at}unsw.edu.au
AbstractIn vitro experiments
suggest that free radicals may contribute importantly to atherogenesis.
Superoxide dismutase (SOD), particularly extracellular SOD (EC-SOD),
which accounts for the majority of SOD biological activity, is a major
superoxide scavenger. We explored factors that may affect plasma EC-SOD
levels measured by ELISA and assessed the association between plasma
EC-SOD and coronary artery disease documented angiographically
in 590 white Australian patients
65 years old. Mean±SEM plasma
EC-SOD in female patients (113.6±13.2 ng/mL) was significantly higher
than in male patients (86.6±5.1 ng/mL, P<0.0001), and
all 19 patients with levels >400 ng/mL were heterozygous for the
Arg213
Gly mutation at the EC-SOD gene; there was also a positive
correlation with age (r=0.131, P=0.0016).
Plasma EC-SOD in current smokers (75.0±9.3 ng/mL) was much lower than
in nonsmokers (111.7±8.2 ng/mL, P<0.01), and
ex-smokers had intermediate levels (84.3±7.1 ng/mL). Levels were
significantly lower in patients with than in those without a history of
acute myocardial infarction (MI) (76.1±7.5 versus 110.1±6.0 ng/mL,
P<0.05), and low plasma EC-SOD was independently
associated with an increased likelihood of a history of MI (OR, 2.04;
95% CI, 1.10 to 3.82); higher EC-SOD levels also tended to be
associated with delayed onset of MI. In conclusion, our study
establishes that in patients assessed by coronary angiography,
circulating EC-SOD is lower in men than in women and in smokers of each
sex and that low levels are independently associated with a history of
MI. These findings are consistent with EC-SOD's being
protective and contributing to reduced coronary risk.
Key Words: extracellular superoxide dismutase extracellular superoxide dismutase Arg213
Gly mutation coronary disease smoking myocardial infarction
This article has been cited by other articles:
![]() |
U. N. Das Exercise and inflammation Eur. Heart J., June 1, 2006; 27(11): 1385 - 1385. [Full Text] [PDF] |
||||
![]() |
D. Aa. Olsen, S. V. Petersen, T. D. Oury, Z. Valnickova, I. B. Thogersen, T. Kristensen, R. P. Bowler, J. D. Crapo, and J. J. Enghild The Intracellular Proteolytic Processing of Extracellular Superoxide Dismutase (EC-SOD) is a Two-step Event J. Biol. Chem., May 21, 2004; 279(21): 22152 - 22157. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Juul, A. Tybjaerg-Hansen, S. Marklund, N. H.H. Heegaard, R. Steffensen, H. Sillesen, G. Jensen, and B. G. Nordestgaard Genetically Reduced Antioxidative Protection and Increased Ischemic Heart Disease Risk: The Copenhagen City Heart Study Circulation, January 6, 2004; 109(1): 59 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pierce, J. Whitlark, and L. Dory Extracellular Superoxide Dismutase Polymorphism in Mice Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1820 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kimura, G. Hasegawa, H. Obayashi, T. Adachi, H. Hara, M. Ohta, M. Fukui, Y. Kitagawa, H. Park, N. Nakamura, et al. Serum Extracellular Superoxide Dismutase in Patients With Type 2 Diabetes: Relationship to the development of micro- and macrovascular complications Diabetes Care, April 1, 2003; 26(4): 1246 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Landmesser, R. Merten, S. Spiekermann, K. Buttner, H. Drexler, and B. Hornig Vascular Extracellular Superoxide Dismutase Activity in Patients With Coronary Artery Disease : Relation to Endothelium-Dependent Vasodilation Circulation, May 16, 2000; 101(19): 2264 - 2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M Klevay Dietary copper and risk of coronary heart disease Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1213 - 1214. [Full Text] [PDF] |
||||
![]() |
D. W. Jacobsen Hyperhomocysteinemia and Oxidative Stress : Time for a Reality Check? Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1182 - 1184. [Full Text] [PDF] |
||||
![]() |
D. E. L. Wilcken, X. L. Wang, T. Adachi, H. Hara, N. Duarte, K. Green, and B. Wilcken Relationship Between Homocysteine and Superoxide Dismutase in Homocystinuria : Possible Relevance to Cardiovascular Risk Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1199 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D Davis, D. B Milne, and F. H Nielsen Changes in dietary zinc and copper affect zinc-status indicators of postmenopausal women, notably, extracellular superoxide dismutase and amyloid precursor proteins Am. J. Clinical Nutrition, March 1, 2000; 71(3): 781 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Mahaney, S. A. Czerwinski, T. Adachi, D. E. L. Wilcken, and X. L. Wang Plasma Levels of Extracellular Superoxide Dismutase in an Australian Population : Genetic Contribution to Normal Variation and Correlations With Plasma Nitric Oxide and Apolipoprotein A-I Levels Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 683 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Klevay Cardiovascular Disease from Copper Deficiency--A History J. Nutr., February 1, 2000; 130(2): 489 - 489. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |